Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.

Aging is accompanied by increased oxidative stress (OS) and accumulation of advanced glycation end products (AGEs). AGE formation in food is temperature-regulated, and ingestion of nutrients prepared with excess heat promotes AGE formation, OS, and cardiovascular disease in mice. We hypothesized that sustained exposure to the high levels of pro-oxidant AGEs in normal diets (Reg(AGE)) contributes to aging via an increased AGE load, which causes AGER1 dysregulation and depletion of anti-oxidant capacity, and that an isocaloric, but AGE-restricted (by 50%) diet (Low(AGE)), would decrease these abnormalities. C57BL6 male mice with a life-long exposure to a Low(AGE) diet had higher than baseline levels of tissue AGER1 and glutathione/oxidized glutathione and reduced plasma 8-isoprostanes and tissue RAGE and p66(shc) levels compared with mice pair-fed the regular (Reg(AGE)) diet. This was associated with a reduction in systemic AGE accumulation and amelioration of insulin resistance, albuminuria, and glomerulosclerosis. Moreover, lifespan was extended in Low(AGE) mice, compared with Reg(AGE) mice. Thus, OS-dependent metabolic and end organ dysfunction of aging may result from life-long exposure to high levels of glycoxidants that exceed AGER1 and anti-oxidant reserve capacity. A reduced AGE diet preserved these innate defenses, resulting in decreased tissue damage and a longer lifespan in mice.

[1]  L. Ferrucci,et al.  Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  H. Hammes,et al.  Methylglyoxal Modification of mSin3A Links Glycolysis to Angiopoietin-2 Transcription , 2007, Cell.

[3]  Feng Chen,et al.  Heterocyclic amines: chemistry and health. , 2006, Molecular nutrition & food research.

[4]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[5]  J. He,et al.  Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor , 2006, Proceedings of the National Academy of Sciences.

[6]  A. D'Angelo,et al.  HIGH LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS MAY BE A MARKER OF EXTREME LONGEVITY IN HUMANS , 2006, Journal of the American Geriatrics Society.

[7]  S. Menini,et al.  Deletion of p66Shc Longevity Gene Protects Against Experimental Diabetic Glomerulopathy by Preventing Diabetes-Induced Oxidative Stress , 2006, Diabetes.

[8]  G. Striker,et al.  Amelioration of oxidant stress by the defensin lysozyme. , 2006, American journal of physiology. Endocrinology and metabolism.

[9]  H. Hammes,et al.  RETRACTED: Methylglyoxal Modification of mSin3A Links Glycolysis to Angiopoietin-2 Transcription , 2006, Cell.

[10]  S. Fields,et al.  Increased Life Span due to Calorie Restriction in Respiratory-Deficient Yeast , 2005, PLoS Genetics.

[11]  Edward J. Masoro,et al.  Overview of caloric restriction and ageing , 2005, Mechanisms of Ageing and Development.

[12]  G. Striker,et al.  Glomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors. , 2005, The American journal of pathology.

[13]  J. Uribarri,et al.  Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. , 2005, Diabetes.

[14]  R. de Caterina,et al.  At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[15]  M. Linton,et al.  Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse. , 2005, Circulation.

[16]  M. Emond,et al.  Extension of Murine Life Span by Overexpression of Catalase Targeted to Mitochondria , 2005, Science.

[17]  S. Genuth,et al.  Glycation Products as Markers and Predictors of the Progression of Diabetic Complications , 2005, Annals of the New York Academy of Sciences.

[18]  A. Smit,et al.  Simple Noninvasive Measurement of Skin Autofluorescence , 2005, Annals of the New York Academy of Sciences.

[19]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[20]  G. Striker,et al.  The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. , 2004, The American journal of pathology.

[21]  A. Bokov,et al.  The role of oxidative damage and stress in aging , 2004, Mechanisms of Ageing and Development.

[22]  D. Rutledge,et al.  Assessment of protein glycation markers in infant formulas , 2004 .

[23]  J. He,et al.  Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Riabowol,et al.  Murine models of life span extension. , 2004, Science of aging knowledge environment : SAGE KE.

[25]  J. Uribarri,et al.  Glycoxidation and Diabetic Complications: Modern Lessons and a Warning? , 2004, Reviews in Endocrine and Metabolic Disorders.

[26]  C. Hsieh,et al.  Altered oxidative stress response of the long-lived Snell dwarf mouse. , 2004, Biochemical and biophysical research communications.

[27]  Ana Rute Neves,et al.  Yeast Life-Span Extension by Calorie Restriction Is Independent of NAD Fluctuation , 2003, Science.

[28]  M. Peppa,et al.  Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. , 2003, Diabetes.

[29]  E. Fisher,et al.  Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice. , 2003, Atherosclerosis.

[30]  Y. Higami,et al.  Lifespan extension by reduction of the growth hormone‐insulin‐like growth factor‐1 axis: relation to caloric restriction , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  J. Latcham,et al.  A longitudinal magnetic resonance imaging (MRI) study of differences in abdominal fat distribution between normal mice, and lean overexpressors of mitochondrial uncoupling protein‐3 (UCP‐3) , 2003, Diabetes, obesity & metabolism.

[32]  J. Uribarri,et al.  Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. , 2003, Journal of the American Society of Nephrology : JASN.

[33]  C. Finch,et al.  Evolutionary Medicine: From Dwarf Model Systems to Healthy Centenarians? , 2003, Science.

[34]  C. Napoli,et al.  Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. A. Zimmerman,et al.  Nutritional control of aging , 2003, Experimental Gerontology.

[36]  Martin Holzenberger,et al.  IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice , 2003, Nature.

[37]  桑迫 崇裕 Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism , 2003 .

[38]  M. Peppa,et al.  Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Yasuo Fukami,et al.  Adaptor Protein Shc Is an Isoform-specific Direct Activator of the Tyrosine Kinase c-Src* , 2002, The Journal of Biological Chemistry.

[40]  M. Peppa,et al.  Oxidative Stress-Inducing Carbonyl Compounds From Common Foods: Novel Mediators of Cellular Dysfunction , 2002, Molecular medicine.

[41]  E. Fisher,et al.  Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. , 2002, Diabetes.

[42]  M. Steffes,et al.  Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products , 2002, Diabetes/metabolism research and reviews.

[43]  S. Nemoto,et al.  Redox Regulation of Forkhead Proteins Through a p66shc-Dependent Signaling Pathway , 2002, Science.

[44]  R. de Caterina,et al.  Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.

[45]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[46]  M. Glomb,et al.  Detection of α-Dicarbonyl Compounds in Maillard Reaction Systems and in Vivo , 2001 .

[47]  A. Schmidt,et al.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.

[48]  T. Koschinsky,et al.  Presence of Diabetic Complications in Type 1 Diabetic Patients Correlates with Low Expression of Mononuclear Cell AGE-Receptor-1 and Elevated Serum AGE , 2001, Molecular medicine.

[49]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[50]  M. Glomb,et al.  Detection of alpha-dicarbonyl compounds in Maillard reaction systems and in vivo. , 2001, Journal of agricultural and food chemistry.

[51]  M. V. van Boekel,et al.  Kinetic aspects of the Maillard reaction: a critical review. , 2001, Die Nahrung.

[52]  Alan W. Stitt,et al.  Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease. , 2000, Kidney international.

[53]  S. Melov,et al.  Extension of life-span with superoxide dismutase/catalase mimetics. , 2000, Science.

[54]  M. F. Weiss,et al.  Mechanisms for the formation of glycoxidation products in end-stage renal disease. , 2000, Kidney international.

[55]  Pier Paolo Pandolfi,et al.  The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.

[56]  H. Vlassara,et al.  Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. , 1999, Diabetes.

[57]  T. Lyons,et al.  Carboxymethylethanolamine, a Biomarker of Phospholipid Modification during the Maillard Reaction in Vivo * , 1997, The Journal of Biological Chemistry.

[58]  R. Bucala,et al.  Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Bucala,et al.  Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  G. Striker,et al.  Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis. , 1995, Kidney international. Supplement.

[61]  G. Striker,et al.  Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. , 1995, Journal of the American Society of Nephrology : JASN.

[62]  E. Friedman,et al.  Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.

[63]  L. Moldawer,et al.  Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. , 1989, The Journal of clinical investigation.

[64]  P. Morrissey,et al.  Nutritional and toxicological aspects of the Maillard browning reaction in foods. , 1989, Critical reviews in food science and nutrition.